Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Clinicopathological features and surgical treatment of thyroid papillary carcinoma in Hashimoto thyroiditis

Bibliographic Data

ID15799855
AuthorsMuhammad Ismail (0000-0002-9437-9212, corresponding author), Abbas Ali Raza (corresponding author), Muhammad Kashif Khan (0000-0002-8734-7087, Bacha Khan University, corresponding author), Umme Salma (0000-0002-1545-2785, Batterjee Medical College, corresponding author), Muhammad Javed Khan (0000-0001-9518-0953, Bacha Khan University, corresponding author), Muhammad Ibrahim Shuja (corresponding author)
Year2023
Volume7
IssueS1
Pages1187-1194
Publication date2023-06-07
Open AccessYes
TypeARTICLE
VenueInternational Journal of Health Sciences (JOURNAL)
Journal identifiersISSN: 2550-696X • E-ISSN: 2550-6978
PublisherUniversidad Tecnica de Manabi (PUBLISHER • EC)
DOI10.53730/ijhs.v7ns1.14332
OpenAlexW4379796275
LanguageEN
References cited1

Background and Aim: Papillary thyroid carcinoma (PTC) is the most prevalent types of thyroid cancer. The present study aimed to investigate the clinicopathological features and surgical treatment of thyroid papillary carcinoma in Hashimoto thyroiditis. Patients and Methods: A cross-sectional study was carried out on 486 papillary thyroid carcinoma patients in the surgical department of Mardan Medical Complex, Mardan Pakistan from March 2020 to March 2023. All the patients were categorized into two groups: Group-I (papillary thyroid carcinoma with Hashimoto thyroiditis) and Group-II (papillary thyroid carcinoma without Hashimoto thyroiditis). Serum thyroid-stimulating hormone (TSH), age, central compartment lymph node metastasis (CLNM), gender, nodular size, and invasive status were different clinicopathological factors recorded. SPSS version 27 was used for data analysis. Results: The overall mean age was 42.84±10.8 years. Out of 486 patients, Group-I had 76 (15.6%) patients whereas Group-II had 410 (84.4%) patients. There were 52 (10.7%) male and 434 (89.3%) females. The incidence of final diagnosis of benign thyroid nodule and PTC was 53.9% (n=262) and 46.1% (n=224) respectively. The prevalence of PT in Group-I was significantly higher 56.8% 57.9% (n=44) than in Group-II 43.4% (n=178)

Carcinoma · Incidence (geometry · Nodule (geology · Pathology · Thyroid · Thyroid cancer · Thyroid carcinoma · Thyroiditis · Medicine · Thyroid Cancer Diagnosis and Treatment · Gastroenterology · Internal Medicine

  • Global Cancer Statistics 2020

    Open Access•Hyuna Sung, Adalberto M Filho et al.•CA: A Cancer Journal for Clinicians•2021

Highly citedNo

Tools

Open DOIOpen Access
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae